Efficacy and Safety Study of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia
Public ClinicalTrials.gov record NCT01968733. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Multi-Center Study to Evaluate the Efficacy and Safety of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in the Treatment of Adult Patients With Community-Acquired Bacterial Pneumonia
Study identification
- NCT ID
- NCT01968733
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Melinta Therapeutics, Inc.
- Industry
- Enrollment
- 863 participants
Conditions and interventions
Conditions
Interventions
- Solithromycin Drug
- Moxifloxacin Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2013
- Primary completion
- Jun 30, 2015
- Completion
- Aug 31, 2015
- Last update posted
- Mar 2, 2017
2013 – 2015
United States locations
- U.S. sites
- 62
- U.S. states
- 24
- U.S. cities
- 56
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Mobile | Alabama | 36607 | — |
| Not listed | Mobile | Alabama | 36609 | — |
| Not listed | Little Rock | Arkansas | 72205 | — |
| Not listed | Chino | California | 91710 | — |
| Not listed | Glendale | California | 91206 | — |
| Not listed | Laguna Hills | California | 92653 | — |
| Not listed | Los Angeles | California | 90015 | — |
| Not listed | Pasadena | California | 91105 | — |
| Not listed | Sacramento | California | 95817 | — |
| Not listed | Sylmar | California | 91342 | — |
| Not listed | Torrance | California | 90502 | — |
| Not listed | Newark | Delaware | 19713 | — |
| Not listed | Bay Pines | Florida | 33744 | — |
| Not listed | DeLand | Florida | 32720 | — |
| Not listed | Doral | Florida | 33166 | — |
| Not listed | Kissimmee | Florida | 34741 | — |
| Not listed | Miami | Florida | 33144 | — |
| Not listed | Miami | Florida | 33156 | — |
| Not listed | West Palm Beach | Florida | 33401 | — |
| Not listed | Augusta | Georgia | 30912 | — |
| Not listed | Blue Ridge | Georgia | 30513 | — |
| Not listed | Decatur | Georgia | 30033 | — |
| Not listed | Chicago | Illinois | 60611 | — |
| Not listed | Springfield | Illinois | 62702 | — |
| Not listed | Council Bluffs | Iowa | 51503 | — |
| Not listed | Hazard | Kentucky | 41701 | — |
| Not listed | Louisville | Kentucky | 40202 | — |
| Not listed | Louisville | Kentucky | 40206 | — |
| Not listed | Owensboro | Kentucky | 42303 | — |
| Not listed | Lafayette | Louisiana | 70503 | — |
| Not listed | Shreveport | Louisiana | 71103 | — |
| Not listed | Detroit | Michigan | 48202 | — |
| Not listed | Farmington Hills | Michigan | 48334 | — |
| Not listed | Royal Oak | Michigan | 48073 | — |
| Not listed | Duluth | Minnesota | 55805 | — |
| Not listed | St Louis | Missouri | 63110 | — |
| Not listed | Butte | Montana | 59701 | — |
| Not listed | Newark | New Jersey | 07102 | — |
| Not listed | Somers Point | New Jersey | 08244 | — |
| Not listed | Buffalo | New York | 14215 | — |
| Not listed | Jamaica | New York | 11418 | — |
| Not listed | Johnson City | New York | 13790 | — |
| Not listed | New York | New York | 10003 | — |
| Not listed | Winston-Salem | North Carolina | 27103 | — |
| Not listed | Akron | Ohio | 44304 | — |
| Not listed | Cincinnati | Ohio | 45267 | — |
| Not listed | Cleveland | Ohio | 44106 | — |
| Not listed | Columbus | Ohio | 43210 | — |
| Not listed | Dayton | Ohio | 45402 | — |
| Not listed | Lima | Ohio | 45801 | — |
| Not listed | Bethleham | Pennsylvania | 18015 | — |
| Not listed | Philadelphia | Pennsylvania | 19141 | — |
| Not listed | Wyomissing | Pennsylvania | 19610 | — |
| Not listed | Rapid City | South Dakota | 57702 | — |
| Not listed | Nashville | Tennessee | 37232 | — |
| Not listed | Houston | Texas | 77011 | — |
| Not listed | Houston | Texas | 77024 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | Houston | Texas | 77093 | — |
| Not listed | Splendora | Texas | 77372 | — |
| Not listed | Charlottesville | Virginia | 22905-2877 | — |
| Not listed | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 208 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01968733, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 2, 2017 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01968733 live on ClinicalTrials.gov.